🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to provide long term safety data of NVA237. Thi...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-10
Trial ID
NCT01697696
Treatments Being Tested
This study compared the efficacy of indacaterol versus placebo in COPD pati...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-04-28
Trial ID
NCT02418468
Treatments Being Tested
This study evaluated the effect of QAB149 on dynamic and static hyperinflat...
Status
Completed
Location
Novartis Investigator Site
Start Date
2008-02
Trial ID
NCT00636961
Treatments Being Tested
This is a randomized, double blind, double dummy, active-controlled, parall...
Status
Terminated
Location
Peking University Third Hospital
Start Date
2024-01-15
Trial ID
NCT06035393
The purpose of this study is to evaluate discontinuation rates of roflumila...
Status
Completed
Location
Multiple Locations
Start Date
2014-05-01
Trial ID
NCT02165826
Treatments Being Tested
This study investigated the effect of exercise and high-dose salbutamol on ...
Status
Completed
Location
Novartis Investigative site
Start Date
2007-08
Trial ID
NCT00531050
Treatments Being Tested
The aim of the present study is to evaluate the superiority of the fixed tr...
Status
Completed
Location
Chiesi Farmaceutici S.p.A.
Start Date
2015-05-29
Trial ID
NCT02579850
The purpose of this study is to demonstrate that the efficacy of the combin...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-07-27
Trial ID
NCT02487498
Treatments Being Tested
This study is to assess the safety and tolerability of two different doses ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-10
Trial ID
NCT01682863
The purpose of this study is to determine the efficacy of indacaterol 55µg ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-11
Trial ID
NCT01959412